Capricor Therapeutics, Inc. (CAPR) Price Prediction & ForecastCAPRCapricor Therapeutics, Inc.

Alphio's CAPR stock price prediction model matches the current Capricor Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.76 (+0.76%). The 1-week path is $6.59 (-1.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Capricor Therapeutics Inc is currently not a strong buy due to its high risk factors, despite some positive catalysts. The current price is $7.83, with a significant year-to-date decline of 72.34%. The RSI is at 35.586, indicating that the stock is oversold, but it also reflects a lack of momentum. The upcoming FDA decision on November 22 could be a major catalyst, but the market sentiment is cautious, with analysts predicting a potential drop in stock price. The main risk is the negative sentiment surrounding the FDA's likely response, which could lead to further declines.

Capricor Therapeutics, Inc. (CAPR) last closed at $6.71, losing -7.70%. These facts feed the 1-day and 1-week CAPR price prediction above.